Tagged: CLDX

Celldex begins 2012 well positioned – CLDX

Celldex Therapeutics, Inc. (NASDAQ: CLDX) reported financial results for the fourth quarter and the year ended December 31, 2011. Celldex reported a net loss of $12.7 million, or ($0.29) per basic and diluted share,...